Tillmann, H., Ganson, N. J., Patel, K., Thompson, A. J., Abdelmalek, M., Moody, T., … Hershfield, M. S. (2010). 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON. In Journal of Hepatology (Vol. 52, pp. S129–S129). Elsevier BV. https://doi.org/10.1016/s0168-8278(10)60309-1

Tillmann, H., N. J. Ganson, K. Patel, A. J. Thompson, M. Abdelmalek, T. Moody, J. G. McHutchison, and M. S. Hershfield. “307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON.” In Journal of Hepatology, 52:S129–S129. Elsevier BV, 2010. https://doi.org/10.1016/s0168-8278(10)60309-1.

Tillmann H, Ganson NJ, Patel K, Thompson AJ, Abdelmalek M, Moody T, et al. 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON. In: Journal of Hepatology. Elsevier BV; 2010. p. S129–S129.

Tillmann, H., et al. “307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON.” Journal of Hepatology, vol. 52, Elsevier BV, 2010, pp. S129–S129. Crossref, doi:10.1016/s0168-8278(10)60309-1.

Tillmann H, Ganson NJ, Patel K, Thompson AJ, Abdelmalek M, Moody T, McHutchison JG, Hershfield MS. 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON. Journal of Hepatology. Elsevier BV; 2010. p. S129–S129.